Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2018 Q1- Text added to 2018 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
agent, allegedly, ARCADE, arm, ATM, capture, Catalyst, CDA, composition, constellation, daily, dosing, ELARA, ELEKTRA, ENDYMION, fourth, gait, hydroxycholesterol, indemnification, infection, male, medicine, myoclonic, Nonrefundable, pertaining, pivotal, placebo, prespecified, pyrexia, ranked, rash, responded, ROCKET, shelf, SKY, tradable, unfavorable, viral
Valuein 2018 Q1 filing- Value in 2018 Q2 filing
Original filings
Filing view